1.Clinicodemographic and duplex scan profiles of patients who underwent hemodialysis access duplex scan in a tertiary institution from 2017 to 2023.
Julianne Marie E. YAMAMOTO ; Jonathan James G. BERNARDO
Philippine Journal of Cardiology 2026;54(1):116-137
BACKGROUND
Hemodialysis access is the lifeline of patients with end-stage renal disease. Factors that can affect access patency needs to be understood further to improve their longevity.
METHODSThis is a cross-sectional descriptive study that aims to describe the demographic, clinical and duplex scan profiles among patients who have undergone arteriovenous fistula (AVF) or graft duplex scan in a tertiary institution from 2017 to 2023.
RESULTSThere were 133 patients with 139 accesses studied. There were 86 AVFs and 53 arteriovenous grafts. Eighty-one studies were on males and 48 on females. Forty-seven were studies on the young (ageCONCLUSION
Age, gender, type of access and comorbidities can be related to the presence of access flow dysfunction. Larger prospective research is recommended to establish such associations.
Human ; Male ; Female ; Renal Dialysis
2.Clinicodemographic and duplex scan profiles of patients who underwent hemodialysis access duplex scan in a tertiary institution from 2017 to 2023.
Julianne Marie E. YAMAMOTO ; Jonathan James G. BERNARDO
Philippine Journal of Cardiology 2026;54(1):116-137
BACKGROUND
Hemodialysis access is the lifeline of patients with end-stage renal disease. Factors that can affect access patency needs to be understood further to improve their longevity.
METHODSThis is a cross-sectional descriptive study that aims to describe the demographic, clinical and duplex scan profiles among patients who have undergone arteriovenous fistula (AVF) or graft duplex scan in a tertiary institution from 2017 to 2023.
RESULTSThere were 133 patients with 139 accesses studied. There were 86 AVFs and 53 arteriovenous grafts. Eighty-one studies were on males and 48 on females. Forty-seven were studies on the young (ageCONCLUSION
Age, gender, type of access and comorbidities can be related to the presence of access flow dysfunction. Larger prospective research is recommended to establish such associations.
Human ; Male ; Female ; Renal Dialysis
3.A Multimodal Approach Using Calcitonin, Denosumab, and Hemodialysis for the Management of Refractory Hypercalcemia in Malignancy
Nur Haziqah Baharum ; Mohd Hazriq A. ; Aimi Fadilah M. ; Nur Aini Eddy Warman ; Fatimah Zaherah MS ; Rohana A.G.
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):78-
Introduction:
Severe hypercalcemia is a life-threatening metabolic
emergency that necessitates prompt initiation of systemic
therapy due to the risk of cardiac arrhythmias. It is
frequently linked to squamous cell carcinoma through the
production of parathyroid hormone–related protein, which
mediates the development of humoral hypercalcemia of
malignancy.
Case:
This is a case of a 38-year-old male who was diagnosed
1 year ago with locally advanced poorly differentiated
basaloid squamous cell carcinoma of the lower anterior
mandibular alveolus involving cortical, medullary bone,
and perineural invasion. He underwent extensive tumor
resection with reconstruction, tracheostomy, and bilateral
neck dissection, followed by multiple revision surgeries
for postoperative complications. He completed adjuvant
chemoradiotherapy.
He presented with acute confusion without other systemic
symptoms. His Glasgow Coma Scale was E4V4M5. Neurological and systemic examinations were unremarkable, and
oral cavity assessment showed no evidence of recurrence.
Investigations revealed severe hypercalcemia (5.94 mmol/L)
with normal phosphate (1.16 mmol/L) associated with
shortened QTc. Other tests were unremarkable, with no
evidence of infection, uremia, liver dysfunction, or alternative metabolic causes. Lumbar puncture was unremarkable.
His parathyroid hormone level was suppressed at 0.50 pg/
mL. Computed tomography brain showed no evidence of
meningoencephalitis, hydrocephalus, cerebral oedema, or
metastasis. Aggressive hydration was initiated alongside
subcutaneous calcitonin, which was subsequently titrated.
However, there was no clinical or biochemical improvement
after 1 day, with persistent confusion and calcium remaining
at 5.87 mmol/L. Subcutaneous denosumab was then
administered, and hemodialysis was initiated on alternate
days due to refractory hypercalcemia. This resulted in improvement of calcium levels to 3.2–3.6 mmol/L and
resolution of confusion
Conclusion
Refractory hypercalcemia may represent a late manifestation of advanced squamous cell carcinoma and is an
ominous prognostic indicator, necessitating prompt
evaluation and oncologic management.
Calcitonin
;
Denosumab
;
Hypercalcemia
;
Renal Dialysis
;
Neoplasms
4.Paediatric NODAT Following Kidney Transplant: Clinical Characteristics of Four Cases at Hospital Tunku Azizah
Rohani Ahmad ; Yap Yok Chin ; Arliena Amin ; Lim Poi Giok
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):134-
Introduction:
New-onset diabetes after transplantation (NODAT) is a clinically significant complication associated with adverse
metabolic and graft outcomes and affects patients’ quality of life. Data in paediatric populations are limited. This case series
describes the incidence, clinical characteristics, and early outcomes of NODAT in a paediatric kidney transplant cohort.
Cases:
Thirty patients (aged 5–17 years; 16 males, 14 females; 14 Malay, 15 Chinese, 1 Indian) underwent renal transplantation
at Hospital Tunku Azizah between 2019 and 2025.
NODAT was identified using standard diagnostic criteria and occurred in four patients (13.3%). Among patients who
developed NODAT, three were Malay and one Chinese; all were aged 10–17 years, with a predominance of females (n = 3).
All were non-obese (body mass index [BMI]: 11–21.4 kg/m²), and only one had a family history of type 2 diabetes mellitus.
Underlying causes of ESRF in these patients included focal segmental glomerulosclerosis (FSGS, n = 2), CAKUT (n = 1),
and unknown etiology (n = 1). Two patients received kidneys from living donors, and two from cadaveric donors. Two
patients demonstrated reduced C-peptide levels, consistent with impaired insulin secretion. All patients received steroid
induction and maintenance therapy alongside tacrolimus-based immunosuppression, with one patient also receiving
everolimus. Two patients developed post-transplant CMV viremia, which has been associated with NODAT.
The onset of NODAT was early, occurring within 2 weeks post-transplant in three patients and at 1 month in one patient.
Insulin therapy achieved glycemic control in all cases. Two patients were able to discontinue insulin within 3–4 months,
suggesting recovery of endogenous glycemic regulation, while the remaining two required ongoing insulin therapy.
Conclusion
NODAT affects a substantial proportion of paediatric kidney transplant recipients and may present despite the absence
of conventional risk factors. Early surveillance is essential. The observed potential for insulin independence may indicate
a reversible component of β-cell dysfunction, which warrants further investigation in larger cohorts.
Child
;
Kidney Transplantation
;
Hospitals
5.Impact of intraoperative blood pressure hypotension on kidney transplant recipients: a retrospective analysis
Maruhum Bonar Hasiholan Marbun ; Nur Rasyid ; Dita Aditianingsih ; Dina Elita ; Priscilla Geraldine Nainggolan ; Michella Chiara Heriyanto ; Jesslyn Mellenia ; Angela Rebecca Tiurmarina Sintauli Hutagulung
Medical Journal of Indonesia 2026;35(3):208-214
BACKGROUND :
Kidney transplantation improves survival and quality of life in end-stage renal disease. However, intraoperative hypotension remains common and may reduce graft perfusion. The optimal intraoperative blood pressure (BP) target remains unclear. This study aimed to evaluate the association between intraoperative BP trends and kidney transplant outcomes.
METHODS :
A retrospective cohort study was conducted among adult living donor kidney transplant recipients (≥18 years) at Cipto Mangunkusumo Hospital, Jakarta, Indonesia, from July 2023–April 2025. Intraoperative BP was recorded every 15 min to calculate average, minimum, and hourly systolic blood pressure (SBP), diastolic blood pressure, and mean arterial pressure (MAP). The primary outcomes were 3-month mortality, delayed graft function (DGF), and acute allograft rejection. Secondary outcomes included early graft function parameters, including serum creatinine levels, estimated glomerular filtration rate (eGFR), and time to first diuresis. Associations between BP and outcomes were analyzed using multivariate logistic regression in SPSS software version 27.0, with p<0.05 considered significant.
RESULTS :
Of 79 transplant recipients, the 3-month mortality was 6.3%, DGF was 7.6%, and acute rejection was 3.8%. Lower intraoperative MAP was associated with increased odds of DGF, with MAP <80 mmHg showing the strongest association (odds ratio [OR]: 88.239; 95% confidence interval [CI]: 2.720–2,092.86). Each 10-mmHg increase in overall SBP was associated with a reduction in the odds of DGF (OR: 0.360; 95% CI: 0.155–0.838). No BP measures were linked to serum creatinine levels (p = 0.083–0.271) or eGFR (p = 0.151–0.791).
CONCLUSIONS
Lower intraoperative MAP and SBP were associated with higher odds of DGF, highlighting the importance of maintaining adequate BP to optimize kidney transplant outcomes.
blood pressure
;
delayed graft function
;
graft rejection
;
kidney transplantation
;
mortality
6.Outcomes of laparoscopic Tenckhoff catheter insertion with rectus sheath tunneling method: a retrospective study
Retta Catherina Sihotang ; Gampo Alam Irdam ; Irfan Wahyudi
Medical Journal of Indonesia 2026;35(3):238-244
BACKGROUND :
Peritoneal dialysis is an alternative to hemodialysis in patients with end-stage kidney disease (ESKD). The laparoscopic technique for catheter insertion has been shown to be better than the open method. This study aimed to discuss the results of laparoscopic Tenckhoff catheter insertion by the rectus sheath tunneling (RST) procedure in adult patients with ESKD.
METHODS :
This retrospective investigation was conducted in an Indonesian tertiary hospital. Data were gathered from the medical records of 18-year-old or older patients with ESKD who underwent laparoscopic Tenckhoff catheter insertion between January 1, 2018 to December 31, 2022.
RESULTS :
Of 68 patients, 45 (66%) were male and 23 (34%) were female, with a mean age of 45.25 (standard deviation: 13.2) years. The catheter survival rates at 3 months, 1 year, 2 years, and 3 years were 97%, 91%, 82%, and 80%, respectively. The estimated blood loss was 5 (2–100) ml and the median operation time was 70 (40–150) min. The omentopexy maneuver was used in 10 (15%) patients. The most common catheter problems were malfunction (18%), peritonitis (21%), exit-site infection (7%), abdominal herniation (3%), and leakage (1%). Because of uncontrolled complications, 9 (13%) patients underwent revision surgery and 10 (15%) required catheter removal surgery. Catheter migration was not observed in any patient.
CONCLUSIONS
Laparoscopic Tenckhoff catheter insertion using the RST technique is a practical method for adult patients with ESKD as it has a reasonably low rate of complications.
complications
;
laparoscopic
;
peritoneal dialysis
7.Risk Factors and a Nomogram Construction for Prolonged Length of Hospital Stay in Patients With Peritoneal Dialysis Associated Peritonitis.
Jing YAO ; Xiao-Jian BAO ; Ya-Feng ZHANG ; Bin WU ; Qi-Shun WU
Acta Academiae Medicinae Sinicae 2025;47(2):244-250
Objective To analyze the risk factors for prolonged length of hospital stay in patients with peritoneal dialysis associated peritonitis(PDAP)and construct a nomogram based on Logistic regression model.Methods A retrospective study was conducted on patients with PDAP who were hospitalized at the Affiliated Hospital of Jiangsu University from January 2013 to December 2023.Using the 75th percentile of hospitalization time as the cutoff(>21 days),the patients were divided into prolonged length of hospital stay group and normal length of hospital stay group.Clinical data were compared between the two groups.Logistic regression analysis was used to analyze the risk factors for prolonged hospital stay in PDAP patients and to construct a nomogram.Results A total of 131 PDAP patients were included in this study,including 40 cases in prolonged length of hospital stay group and 91 cases in normal length of hospital stay group.Multivariate Logistic regression analysis showed that Gram-negative bacteria detected in ascites(OR=6.012,95% CI=1.878-19.248,P=0.003)and elevated platelet count(OR=1.010,95% CI=1.005-1.015,P<0.001)were independent risk factors for prolonged length of hospital stay,while elevated serum chloride(OR=0.885,95% CI=0.802-0.978,P=0.016)was a protective factor.Based on the above three indicators,a nomogram was constructed.The multivariate Logistic regression model showed an area under the receiver operating characteristic curve(AUC)of 0.755,with an internal validation AUC of 0.727 using the Bootstrap method.The calibration curve indicated that the predicted probability was consistent with the actual probability.The decision curve showed that the model was clinically applicable when the threshold probabilities were 9%-10%,13% and 18%-92%.Conclusion A nomogram,based on the detection of gram-negative bacteria in ascites,platelet count and serum chloride,was helpful for clinical screening PADP patients at risk for prolonged length of hospital stay,and can provide a basis for optimizing clinical decision-making.
Humans
;
Nomograms
;
Risk Factors
;
Peritoneal Dialysis/adverse effects*
;
Retrospective Studies
;
Length of Stay
;
Peritonitis/etiology*
;
Logistic Models
;
Male
;
Female
;
Middle Aged
;
Aged
8.Elevated advanced glycation endproducts is a risk factor for stenosis after primary arteriovenous fistula surgery.
Tianhong LI ; Xinfang QIN ; Lili WEI ; Huixin BI
Journal of Southern Medical University 2025;45(8):1663-1671
OBJECTIVES:
To investigate the effect of serum advanced glycation endproducts (AGEs) on stenosis after first autologous arteriovenous fistula (AVF) in patients with end-stage renal disease (ESRD).
METHODS:
Patients with ESRD undergoing standard native arteriovenous fistula (AVF) for the first time in the Department of Nephrology, Affiliated Hospital of Guilin Medical University from February to June 2022 were prospectively enrolled. The preoperative general data, clinical examination results and ultrasound data of the operated limbs were collected. The patients with and without stenosis within 2 months after the operation were compared for preoperative serum AGEs levels detected using ELISA and the clinical parameters. Logistic regression analysis was used to analyze the independent risk factors of AVF stenosis, and the sensitivity and specificity of AGEs for predicting postoperative stenosis were analyzed using receiver-operating characteristic (ROC) curve.
RESULTS:
Of the 94 patients enrolled, 34 had postoperative arteriovenous stenosis and 60 had no stenosis. The number of diabetic patients differed significantly between stenosis group and non-stenosis group (P<0.001). Serum AGEs levels, which were negatively correlated with serum phosphorus level (P<0.05), were significantly higher in stenosis group than in non-stenosis group (Z=-2.837, P=0.005). Serum AGE level was an independent risk factor for postoperative stenosis after AVF (OR=1.251, 95% CI:1.096-1.423, P<0.001). For predicting AVF stenosis, the area under the ROC curve (AUC) of AGEs was 0.677 (P=0.007, 95% CI: 0.572-0.770), with a specificity of 90.00% and a sensitivity of 52.94% at the optimal cut-off value of 8.43 µg/mL; AGEs combined with fibrinogen had an AUC of 0.763 (P<0.001, 95% CI: 0.664-0.844), with a specificity of 73.33% and a sensitivity of 70.59% at the optimal cut-off value of 0.30.
CONCLUSIONS
Elevated serum AGEs level is an independent risk factor for postoperative AVF stenosis, and its combination with fibrinogen has a better efficacy for predicting postoperative AVF stenosis.
Humans
;
Glycation End Products, Advanced/blood*
;
Risk Factors
;
Arteriovenous Shunt, Surgical/adverse effects*
;
Kidney Failure, Chronic/blood*
;
Male
;
Constriction, Pathologic/etiology*
;
Female
;
Middle Aged
;
Postoperative Complications/etiology*
;
Renal Dialysis
;
Aged
;
Prospective Studies
;
ROC Curve
;
Adult
9.Effect of different filters on the efficacy in patients with sepsis-associated acute kidney injury.
Wenjie ZHOU ; Tian ZHAO ; Qi MA ; Xigang MA
Chinese Critical Care Medicine 2025;37(1):48-52
OBJECTIVE:
To investigate the effects of using different filters in continuous renal replacement therapy (CRRT) on the mortality, inflammatory mediator level and hemodynamics in patients with sepsis-associated acute kidney injury (SA-AKI).
METHODS:
A prospective study was conducted. The patients with SA-AKI undergoing first CRRT admitted to the critical care medicine department of General Hospital of Ningxia Medical University from August 2022 to October 2023 were enrolled as the study objects, and they were divided into observation group and control group by random number table method. All patients received routine treatment including anti-infection, optimized volume management and organ function support. On this basis, the observation group was treated with oXiris filter for CRRT, while the control group was treated with ordinary filter for CRRT, and the first treatment time was ≥ 36 hours. General data of the two groups were collected and compared. At the same time, the inflammatory indicators [high-sensitivity C-reactive protein (hs-CRP), procalcitonin (PCT), interleukin-6 (IL-6)], sequential organ failure assessment (SOFA) score, mean arterial pressure (MAP), blood lactic acid (Lac), noradrenaline dosage and other related indicators were collected before CRRT treatment and 24 hours and 48 hours after treatment, and the 7-day and 28-day mortality of patients were recorded.
RESULTS:
Finally, 65 patients were enrolled, including 30 in the observation group and 35 in the control group. There were no significant differences in baseline data including age, gender, acute kidney injury (AKI) stage and infection source between the two groups. The 7-day mortality of observation group was significantly lower than that of control group [16.7% (5/30) vs. 42.9% (15/35), P < 0.05]. There was no significant difference in 28-day mortality between the observation group and the control group [36.7% (11/30) vs. 54.3% (19/35), P > 0.05]. There were no significant differences in inflammation indicators, SOFA score, MAP, Lac and norepinephrine dosage before treatment between the two groups. After 24-hour and 48-hour treatment, the hemodynamics of the two groups were stable compared with before treatment, the inflammatory indicators, SOFA score, Lac and norepinephrine dosage were reduced to varying degrees, and MAP was significantly increased. In the observation group, hs-CRP, PCT, IL-6, SOFA score, MAP, and norepinephrine dosage showed statistical significance at 24 hours after treatment as compared with before treatment [hs-CRP (mg/L): 125.0 (105.0, 171.2) vs. 280.5 (213.2, 313.8), PCT (μg/L): 51.0 (20.0, 62.8) vs. 71.0 (10.8, 100.0), IL-6 (ng/L): 1 762.2 (300.8, 4 327.5) vs. 4 447.5 (630.4, 5 000.0), SOFA score: 13.0 (12.0, 14.0) vs. 16.0 (15.0, 17.0), MAP (mmHg, 1 mmHg ≈ 0.133 kPa): 79.00±12.87 vs. 65.20±11.70, norepinephrine dosage (μg×kg-1×min-1): 0.82±0.33 vs. 1.63±0.51, all P < 0.05]. In the control group, PCT and MAP showed statistical significance after 48 hours of treatment as compared with before treatment. Compared with the control group, hs-CRP, SOFA score and norepinephrine dosage after 48 hours of treatment in the observation group were significantly decreased [hs-CRP (mg/L): 87.2 (74.2, 126.0) vs. 157.0 (88.0, 200.0), SOFA score: 11.0 (10.0, 12.0) vs. 12.0 (10.0, 14.0), norepinephrine dosage (μg×kg-1×min-1): 0.51±0.37 vs. 0.81±0.58, all P < 0.05], MAP was significantly increased (mmHg: 82.00±8.71 vs. 77.77±7.80, P < 0.05).
CONCLUSION
In the treatment of CRRT, oXiris filter can reduce the short-term mortality of SA-AKI patients, lower inflammatory mediators levels and improve hemodynamics, showing therapeutic advantages over conventional filters.
Humans
;
Acute Kidney Injury/etiology*
;
Sepsis/therapy*
;
Prospective Studies
;
Interleukin-6
;
Continuous Renal Replacement Therapy/methods*
;
C-Reactive Protein
;
Male
;
Female
;
Middle Aged
;
Hemodynamics
;
Procalcitonin
;
Aged
10.Design and application of an intelligent temperature-controlled peritoneal dialysis belt.
Chinese Critical Care Medicine 2025;37(2):177-179
Peritoneal dialysis (PD) is one of the main renal replacement therapy methods for patients with end-stage chronic kidney disease, and peritoneal dialysis belt is a key auxiliary device. However, there are some problems in the existing PD technology, such as the separation of heating system and dialysate system, the inability to continuously heat dialysate and the single function of peritoneal dialysis belt. In order to solve the above problems, the staff of Shanghai Geriatric Medical Center designed an intelligent temperature-controlled peritoneal dialysis belt and obtained the National Utility Model Patent of China (patent number: ZL 2023 2 1815961.9). The intelligent temperature-controlled peritoneal dialysis belt is composed of a double-layer fixed belt, an intelligent temperature control system (including temperature control structure and intelligent control system) and other auxiliary structures. The peritoneal dialysis tube can penetrate into the dissection from the entry of the inner surface of the fixed belt and pass through the exit of the outer surface. The double-layer fixed belt ensures the stable fixation of the dialysis tube. The two ends of the fixing belt are designed with magic stickers to adjust the tightness of the fixing belt to adapt to people with different waist circumferences. The interlayer is equipped with an intelligent temperature control system, which can continuously heat the dialysate through an electric heating plate to maintain a temperature close to the body temperature. Through the display screen and controller on the intelligent control system, medical staff can be allowed to monitor and adjust the temperature, pressure and flow parameters of the dialysate in real time. In addition, a cloth with a pulling chain is designed on the inner surface of the fixed belt, and the cloth is opened to facilitate the medical staff to wear the peritoneal dialysis tube in the temperature control structure or the restraint belt. The intelligent temperature-controlled peritoneal dialysis belt enhances the effectiveness of PD, saves PD resources, improves the convenience of PD, is suitable for family and hospital use, can effectively improve the quality of life of patients with chronic renal failure, and is suitable for clinical promotion.
Peritoneal Dialysis/instrumentation*
;
Humans
;
Equipment Design
;
Temperature
;
Kidney Failure, Chronic/therapy*
;
Dialysis Solutions


Result Analysis
Print
Save
E-mail